Related Experiment Video

Updated: Dec 26, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K

Re: Apalutamide and Overall Survival in Non-metastatic Castration-resistant Prostate Cancer

Henk G van der Poel1

  • 1Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

European Urology
|March 17, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Serum and Plasma Copy Number Detection Using Real-time PCR
09:21

Serum and Plasma Copy Number Detection Using Real-time PCR

Published on: December 15, 2017

11.8K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.1K

Related Experiment Videos

Last Updated: Dec 26, 2025

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.6K
Serum and Plasma Copy Number Detection Using Real-time PCR
09:21

Serum and Plasma Copy Number Detection Using Real-time PCR

Published on: December 15, 2017

11.8K
Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
12:13

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

7.1K

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

592
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
592

Articles linked to this work by shared authors, journal, and citation graph.

Molecular imaging tracers targeting c-MET: a systematic review of preclinical evidence and clinical translation.

European journal of nuclear medicine and molecular imaging·2026

Oncological Outcomes of Robot-assisted PSMA-guided Salvage Surgery in Recurrent Prostate Cancer: Insights from the Prospective TRACE-I Trial.

European urology focus·2026

Precise and minimally invasive localization of pelvic nodes during robot-assisted surgery using image-guided navigation.

International journal of computer assisted radiology and surgery·2026

Real-time surgical navigation for intraoperative lymph node localization during targeted robot-assisted pelvic and retroperitoneal lymph node dissection.

Surgical endoscopy·2026

LiDAR-registered freehand SPECT combined with NIR-fluorescence enables spatial localisation of tracer-avid inguinal lymph nodes: A clinical feasibility study.

European journal of nuclear medicine and molecular imaging·2026

Ten-year update on the European Association of Urology Robotic Section (ERUS) fellowship training for robot-assisted radical prostatectomy.

BJUI compass·2026

Major Adverse Cardiovascular Events in Men with High-risk Localized or Metastatic Prostate Cancer Starting Long-term Hormone Therapy in the STAMPEDE Trial.

European urology·2026

Accumulating Evidence Supports NECTIN4 as a Predictive Biomarker for Enfortumab Vedotin: The Compartment Still Matters.

European urology·2026

PSMA-PET/CT-guided Intensification of Radiation Therapy for Prostate Cancer (PSMAgRT): 5-yr Analysis of a Phase 2 Randomized Controlled Trial.

European urology·2026

Low-dose radiotherapy as an immunomodulator in cancer: dose-specific mechanisms and hybrid high-dose/low-dose strategies.

Biomarker research·2026

Uncertainty-aware registration for probabilistic margin assessment in renal cell carcinoma ablation.

Physics in medicine and biology·2026

FLASH radiotherapy for electrons and protons: roadmap towards the clinical introduction.

Physics in medicine and biology·2026

Skin thermal damage as an independent pathophysiological entity: Molecular mechanisms distinct from photoaging and implications for systemic conditioning strategies.

Journal of thermal biology·2026

First attempt of boron neutron capture therapy for adenoid cystic carcinoma liver metastasis: a case report and literature review.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2026

A Tumor-Targeting Perovskite Quantum Dot with High Luminescence and Stability for Radiotherapy Sensitization through X-ray-Activated Photoelectrocatalysis.

ACS applied bio materials·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us